Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Ruth Lagman, MD, was born in Manilla, Philippines. She finished her Bachelor of Science in Zoology from the University of the Philippines in 1982. She obtained her Doctor of Medicine degree from the University of Santo Tomas, Faculty of Medicine and Surgery, in Manila in 1986. She then spent a clinical-internship year followed by a brief stint as a volunteer physician in rural Philippines. Her experience in rural Philippines motivated her to pursue a master’s degree in Public Health at the Department of Epidemiology and Public Health at Yale University with a concentration in the epidemiology of infectious disease. The degree was conferred in 1993 upon completion of her master's thesis.
Dr. Lagman did her internal medicine residency at the University of Connecticut Health Center in Farmington, Conn., from 1990-1993. She then returned home to the Philippines and spent a year teaching at the College of Medicine at Angeles University in Pampanga, Philippines. In 1995, she entered the clinical fellowship program in Palliative Care at the Cleveland Clinic Foundation. She then spent the next few years in private practice, in general internal medicine in the greater Chicago area.
She returned to Cleveland, Ohio, in July 2001 to join the medical staff of the Harry R. Horvitz Center for Palliative Medicine, Department of Hematology and Oncology, at Cleveland Clinic. She also has been appointed Director of Clinical Services of the Palliative Medicine program, and Medical Director of the Hospice of Cleveland Clinic. Her interests are music therapy and complementary and alternative medicine.
Dr. Lagman enjoys traveling, swimming and golf. She is married to Yew Sing Thomas Lee, an associate professor at the University of Illinois at Chicago.
Palliative medicine, cancer, cancer anorexia and cachexia, cancer fatigue, cancer symptoms, chemotherapy related symptoms
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Lagman's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.